Stevanato Group (STVN) stock

Drug containment , market cap $5.5B

Drug containment

Market cap $5.5B

$19.74

+1.86%

As of Monday's close · Live for Pro members at the open

Quality Score

Below Average

In its industry

#45of 85

Medical Devices

Checks firing

2of 14

Transition

From 52-week high

-26.9%

Above the 200-day

STVN's Quality Score rose 1 point on Mon, Nov 2, to 4. Its price climbed back above its average of the last 200 days.

See STVN's 14 chart checksSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why is STVN down?

Its price fell 29% over three years while the S&P 500's rose 82%.

Its operating margin went from 19.6% in fiscal 2022 to 16.8% in fiscal 2025.

Sources: Price history, Oct 30, 2026; Annual reports, Dec 31, 2025

The other side and the timeline, for Pro members.

Get an alert when STVN's Quality Score turns up →

Key facts on STVN

Key facts on STVN
Since its 2023 high	Down 45% profit EUR 145.6M → EUR 139.8M a year
Latest filing	20-F, Mar 4 Filed its annual report (20-F) for the year to Dec 31, 2025

1 more reason behind STVN's 4, free with an account →

STVN in the news

ReportReports tomorrow, before the open. Every 3 months, a company tells everyone how much it sold and earned. It fell after 3 of its last 4 reports, +1.7% on average. Past reports ›

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

STVN catalysts

Coming up

After its last 4 reports it closed +1.7% on average, higher 1 of 4 times.

4 past catalysts since 2024, with sizes and sources, for Pro members.Get in free →

Here is what Pro members see.

The same page for Pro members, on AMD
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on STVN and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

STVN has 2 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on STVN, and all 14 on every stock.Get in free →

STVN RSI today: 49.1, below its 50-day, above its 200-day

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

RSI 1449.1
Above 30, below 50.
MACD (12, 26, 9)Above signal
Crossed above its signal line 6 sessions ago.
50-day average$20.52
The price is 3.8% below it.
200-day average$18.09
The price is 9.1% above it.
50/200 crossGolden cross
The 50-day crossed above the 200-day on Aug 6.
ADX 1419.9
Under 25, with +DI below -DI.
Support$19.00
Swing low from Aug 4, 3.7% below the price.
Resistance$19.77
Swing high from Jun 5, 0.2% above the price.
52-week high$27.00
From Nov 6, 2025, 36.8% above the price.
52-week low$12.89
From Mar 27, 34.7% below the price.
Chart patternNone
No triangle, channel, or wedge in the last year.
Bollinger Bands (20, 2)Inside
The bands run from $18.72 to $20.08.
Volume2.0x
Against its 20-day average, for the time of day.

The deep dive on STVN

What it does and how it makes money4 findingsFor Pro members4 findings on what STVN does and how it makes money, for Pro members
Where it stands1 findingFor Pro members1 finding on where STVN stands: its cash, debt, and share count, for Pro members
What changed in its filings1 findingA new heading in its "Risk Factors" this year: "Our use of new and evolving technologies, such as artificial intelligence, may present risks and challenges that can impact our business, including by posing cybersecurity and other risks to our confidential and/or proprietary information …" (20-F for fiscal 2025; not in fiscal 2024's)SEC filing · Mar 4, 2026, against the one of Mar 6, 2025
Who holds and trades it3 findingsFor Pro members3 findings on who holds and trades STVN, for Pro members
Against its closest peers2 peersFor Pro membersSTVN against 2 peers, fact by fact, for Pro members

8 more findings on STVN, each with its source, for Pro membersGet in free →

How STVN ranks in Medical Devices

STVN is #45 of 85 by Quality Score.

How STVN ranks in Medical Devices
1	ATRCAtriCure	7/14	18
2	HAEHaemonetics	7/14	17
3	WSTWest Pharmaceutical Services	6/14	17
	STESTERIS		Open for its score
	STIMNeuronetics		Open for its score
	STXSStereotaxis		Open for its score
	SYKStryker		Open for its score
45	STVNStevanato	2/14	4

When does STVN report earnings, and what happens after?

Reports Tue Nov 3, before the open (tomorrow). Confirmed.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

+18.8%-5.1%-4.6%

Mar 4May 7Aug 4

Reported	When	Gap	Reaction	5 sessions
Aug 4, 2026Before open	Before open	-2.4%	-4.6%	-0.1%
May 7, 2026Before open	Before open	-4.7%	-5.1%	-6.0%
Mar 4, 2026Before open	Before open	+9.5%	+18.8%	+2.3%

STVN closed higher after 1 of its last 4 reports.

9 quarters of STVN’s results read from its 6-K filings, the newest filed Aug 4, 2026: its sales and profit, quarter by quarter, for Pro members.Get in free →

All 4 reports, and STVN's Quality Score going into each

Everyone reporting earnings this week

STVN sales and profit by year

Sales and profit by year

Sales grew every year from 2019 to 2025, to €1.2B. It made a profit in each of the seven years.

Insiders trading STVN

STVN insider trades

8 insiders sold $562K across 8 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellMauro Stocchi$293KInsiderat $21.50 on Sep 28, filed Sep 30

SellMauro StocchiInsider$293Kat $21.50 on Sep 28, filed Sep 30

All 8 insider filings on STVN from the last six months, for Pro members.Get in free →

All STVN insider trades

STVN's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Marco Dal LagoChief Financial Officer · 1 trade
Mauro StocchiOfficer · 1 trade
Donald E. Morel Jr.Director · 1 trade
Elisabetta MagistrettiDirector · 1 trade
Karen FlynnDirector · 1 trade
Luciano SantelDirector · 1 trade
Madhavan BalachandranDirector · 1 trade
William J. FedericiDirector · 1 trade

One more officer or director files at STVN. Each page above names the rest.

See insider trades by person

About Stevanato Group

Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.

5,795 employeesstevanatogroup.com

What Stevanato Group says it competes with

“We compete across a broad spectrum of products, processes and services for integrated containment and delivery solutions as well as engineering solutions.”

From its annual report, SEC filing · Mar 4, 2026

2 more sentences, what it says it does, and its sales by region, for Pro membersGet in free →

STVN's score card

Stevanato Group (STVN): Quality Score 4, Below Average, #45 of 85 in Medical Devices, with its price, on Breakaway — The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

What would turn STVN's score around: 6 things
Real-⁠time prices, no delay
Every line of STVN's score, with the points and the reason

BreakawaySep 30Mauro Stocchi sold STVN$293K at $21.50, filed Sep 30

Alerts are optional.

See STVN's 14 chart checks

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 2, 2026: STVN's Quality Score is 4 (Below Average), #45 of 85 in Medical Devices. Insiders sold $562K in the last 6 months (Form 4).

Is STVN a good stock to buy? What its Quality Score says

STVN scores 4 today, which Breakaway calls Below Average. It is #45 of 85 in Medical Devices by Quality Score, with 2 of 14 chart checks firing. Its price fell 29% over three years while the S&P 500's rose 82%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is STVN's Quality Score?

STVN scores 4 today, which Breakaway calls Below Average (0 to 5). That is #45 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind STVN's 4.

Are insiders buying STVN?

8 insiders sold $562K across 8 filings in the last 6 months. No open-⁠market buys on record. The newest is Mauro Stocchi, Insider, who sold $293K on Sep 28. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.